Holen Sie sich die Stockscreener-App
78.19
0.23%
-0.305
Schlusskurs vom Vortag:
$78.50
Offen:
$78.39
24-Stunden-Volumen:
144.02K
Relative Volume:
0.12
Marktkapitalisierung:
$12.87B
Einnahmen:
$8.31B
Nettoeinkommen (Verlust:
$379.00M
KGV:
36.20
EPS:
2.16
Netto-Cashflow:
$385.00M
1W Leistung:
+3.27%
1M Leistung:
+4.65%
6M Leistung:
+12.84%
1J Leistung:
+56.95%
1-Tages-Spanne:
$77.97
$78.86
1-Wochen-Bereich:
$76.34
$78.86
52-Wochen-Spanne:
$47.16
$85.92
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Vergleichen Sie SOLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
78.23 | 12.87B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
539.16 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
174.75 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.48 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
257.17 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
223.89 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Solventum Named a Best Company to Work for by U.S. News & World Report - Stock Titan
How Did Solventum Corporation's (NYSE:SOLV) 12% ROE Fare Against The Industry? - Yahoo Finance
With 68% ownership, Solventum Corporation (NYSE:SOLV) boasts of strong institutional backing - simplywall.st
SOLV Q1 Earnings Call: Margin Headwinds Offset by Volume Growth and Product Momentum - Yahoo Finance
Solventum Launches Preassembled, See-through VH2O2 Test Pack for Low-temp Medical Instrument Sterilization - PR Newswire
Legacy and innovation on show as Solventum unveils new products - Dentistry UK
Keybanc Initiates Coverage of Solventum (BIT:1SOLV) with Sector Weight Recommendation - Nasdaq
Q1 Rundown: Solventum (NYSE:SOLV) Vs Other Surgical Equipment & ConsumablesDiversified Stocks - MSN
Keybanc Initiates Coverage of Solventum (SOLV) with Sector Weight Recommendation - Nasdaq
Keybanc Initiates Coverage of Solventum (LSE:0AD1) with Sector Weight Recommendation - Nasdaq
KeyBanc Initiates Solventum at Sector Weight - MarketScreener
Solventum initiated with a Sector Weight at KeyBanc - TipRanks
KeyBanc initiates Solventum stock with Sector Weight rating - Investing.com India
KeyBanc initiates Solventum stock with Sector Weight rating By Investing.com - Investing.com South Africa
SOLV's Strong Q1 Signals Turnaround: Is the Stock Worth Betting Now? - MSN
Solventum to Participate in the 2025 Goldman Sachs Health Care Conference - Kilgore News Herald
Solventum to Participate in the 2025 Goldman Sachs Health Care C - GuruFocus
Solventum Stock Earns RS Rating Upgrade - Investor's Business Daily
Ensemble and Solventum to launch autonomous coding solution for hospitals - MSN
Solventum Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Ameriprise Financial Inc. Boosts Stake in Solventum Co. (NYSE:SOLV) - Defense World
Piper Sandler Upgrades Solventum (BIT:1SOLV) - Nasdaq
Piper Sandler Upgrades Solventum (LSE:0AD1) - Nasdaq
Ensemble and Solventum Partner to Advance Autonomous Inpatient Coding with AI - The Manila Times
Piper Sandler Upgrades Solventum (BMV:SOLV) - Nasdaq
Piper Sandler Upgrades Solventum (SOLV) - Nasdaq
Assessing Solventum: Insights From 9 Financial Analysts - Benzinga
Piper Sandler raises Solventum stock to Overweight, target to $87 By Investing.com - Investing.com Nigeria
Piper Sandler raises Solventum stock to Overweight, target to $87 - Investing.com
Piper Sandler Upgrades Solventum to Overweight From Neutral, Adjusts Price Target to $87 From $78 - marketscreener.com
Solventum upgraded to Overweight from Neutral at Piper Sandler - TipRanks
Promising Growth and Strategic Flexibility: A Buy Recommendation for Solventum Corporation - TipRanks
After spinoff, 3M is no longer one of Minnesota’s five largest public companies - MSN
Solventum's (NYSE:SOLV) Shareholders Have More To Worry About Than Only Soft Earnings - simplywall.st
Solventum's (NYSE:SOLV) Problems Go Beyond Weak Profit - Yahoo Finance
Solventum Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
People moves: Linda Pazin joins Solventum and Mitch Haws moves to Semtech - IR Impact
Solventum To Present At BofA Securities Health Care Conference; Webcast At 5:20 PM ET - Nasdaq
Solventum sells purification business for $4.1B to pay down debt - MSN
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - MSN
Solventum’s projected $100M tariff hit prevents earnings increase - MedTech Dive
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline - MSN
Solventum, facing tariffs of up to $100 million, raises sales guidance - MSN
Solventum Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st
Decoding Solventum Corp (SOLV): A Strategic SWOT Insight - GuruFocus
Solventum beats first-quarter profit estimates on strong surgical product sales - MSN
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Solventum Corp-Aktie (SOLV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hanson Bryan C | Chief Executive Officer |
May 13 '25 |
Option Exercise |
0.00 |
34,315 |
0 |
75,108 |
| Harris Bernard A Jr | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Edwards Shirley Ann | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '25 |
Option Exercise |
0.00 |
2,375 |
0 |
2,375 |
| DeVore Susan D. | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| ALBAN CARLOS | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '25 |
Option Exercise |
0.00 |
3,959 |
0 |
11,220 |
| Wendell Amy McBride | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| MAY KAREN J | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Mily Elizabeth | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,626 |
2.25%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):